Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |